Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections

Top Antivir Med. 2023 Dec 5;31(5):566-575.ABSTRACTDoxycycline postexposure prophylaxis (doxy-PEP) is a novel strategy now demonstrated in several clinical trials to dramatically reduce incidence rates of gonorrhea, chlamydia, and syphilis in some key populations at high risk of sexually transmitted infections. Even so, much remains unknown about the long-term consequences of doxy-PEP, and several concerns, including the potential for the development of antibiotic resistance and disturbances to the microbiome, balance the benefits. This review highlights the history of antibiotic prophylaxis for sexually transmitted infections, and the rationale, current evidence, and future directions for doxy-PEP.PMID:38198668 | PMC:PMC10776032
Source: Topics in antiviral medicine - Category: Infectious Diseases Authors: Source Type: research